| Product NDC: | 14783-018 |
| Proprietary Name: | LBel Paris |
| Non Proprietary Name: | Octinoxate, Octocrylene, and Oxybenzone |
| Active Ingredient(s): | .075; .05; .03 g/g; g/g; g/g & nbsp; Octinoxate, Octocrylene, and Oxybenzone |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 14783-018 |
| Labeler Name: | Ventura International LTD |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20100815 |
| Package NDC: | 14783-018-41 |
| Package Description: | 1 JAR in 1 BOX (14783-018-41) > 1 g in 1 JAR (14783-018-42) |
| NDC Code | 14783-018-41 |
| Proprietary Name | LBel Paris |
| Package Description | 1 JAR in 1 BOX (14783-018-41) > 1 g in 1 JAR (14783-018-42) |
| Product NDC | 14783-018 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate, Octocrylene, and Oxybenzone |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20100815 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Ventura International LTD |
| Substance Name | OCTINOXATE; OCTOCRYLENE; OXYBENZONE |
| Strength Number | .075; .05; .03 |
| Strength Unit | g/g; g/g; g/g |
| Pharmaceutical Classes |